XML 25 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Underwritten Public Offering
ATM Agreement
Common Stock
Common Stock
Underwritten Public Offering
Common Stock
ATM Agreement
Additional Paid-in Capital
Additional Paid-in Capital
Underwritten Public Offering
Additional Paid-in Capital
ATM Agreement
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2023 $ 74,937     $ 2     $ 587,942     $ (513,007)  
Balance, shares at Dec. 31, 2023       186,960,193              
Stock-based compensation 13,103           13,103        
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ 76,694           $ 76,694      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares         17,596,113            
Issuance of common stock upon vesting and settlement of restricted stock units, net (9)           (9)        
Issuance of common stock upon vesting and settlement of restricted stock units, net, shares       234,198              
Issuance of common stock under ESPP 89           89        
Issuance of common stock under ESPP, shares       93,970              
Issuance of common stock upon exercise of stock options 40           40        
Issuance of common stock upon exercise of stock options, shares       58,832              
Gain (loss) on instrument-specific credit risk (4,031)                   $ (4,031)
Net loss (89,298)                 (89,298)  
Balance at Dec. 31, 2024 $ 71,525     $ 2     677,859     (602,305) (4,031)
Balance, shares at Dec. 31, 2024 204,943,306     204,943,306              
Stock-based compensation $ 13,298           13,298        
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ 215,646     $ 1     $ 215,645      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares         57,777,777            
Issuance of common stock, net of sales commissions and other offering costs     $ 48,435           $ 48,435    
Issuance of common stock, net of sales commissions and other offering costs, shares           10,230,186          
Issuance of common stock upon exercise of pre-funded warrants, shares       9,607,145              
Issuance of common stock upon exercise warrants 1,862           1,862        
Issuance of common stock upon exercise warrants, shares       316,667              
Issuance of common stock upon vesting and settlement of restricted stock units, net (51)           (51)        
Issuance of common stock upon vesting and settlement of restricted stock units, net, shares       1,299,156              
Issuance of common stock under ESPP 159           159        
Issuance of common stock under ESPP, shares       123,151              
Issuance of common stock upon exercise of stock options 1,220           1,220        
Issuance of common stock upon exercise of stock options, shares       754,260              
Gain (loss) on instrument-specific credit risk 3,839                   3,839
Net loss (108,995)                 (108,995)  
Balance at Dec. 31, 2025 $ 246,938     $ 3     $ 958,427     $ (711,300) $ (192)
Balance, shares at Dec. 31, 2025 285,051,648     285,051,648